Assessing Align Technology (ALGN) Valuation After Invisalign Mandibular Launch and 6% Share Price Jump

Simply Wall St.12-03

Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588043140?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/24568-main-header/1590545426137","is_english":true,"pubTime":"2025-12-03 19:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588043140","market":"nz","top_or_hot":-1,"title":"Assessing Align Technology (ALGN) Valuation After Invisalign Mandibular Launch and 6% Share Price Jump","media":"Simply Wall St.","content":"<div>\n<p>Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/assessing-align-technology-algn-valuation-after-invisalign-m\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Align Technology (ALGN) Valuation After Invisalign Mandibular Launch and 6% Share Price Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Align Technology (ALGN) Valuation After Invisalign Mandibular Launch and 6% Share Price Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-03 19:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/assessing-align-technology-algn-valuation-after-invisalign-m><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/assessing-align-technology-algn-valuation-after-invisalign-m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2106854487.HKD","symbol_name":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/assessing-align-technology-algn-valuation-after-invisalign-m","article_id":"2588043140","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/24568-main-header/1590545426137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/assessing-align-technology-algn-valuation-after-invisalign-m","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588043140","pubTimestamp":1764760666,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on the news.\nSee our latest analysis for Align Technology.\nThe upbeat reaction to the Philippines launch sits against a tougher backdrop, with a roughly 9% one month share price return, but a year to date share price return still down about 28%, and a one year total shareholder return of around...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1917777945.USD":"安联专题基金Cl AT Acc","BK4588":"碎股","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","BK4585":"ETF&股票定投概念","BK4198":"医疗保健用品","BK4534":"瑞士信贷持仓","BK4504":"桥水持仓","ALGN":"艾利科技","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD"},"translate_title":"Invisalign Mandibular上市后评估Align Technology(ALGN)的估值以及股价上涨6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALGN":1.5},"content_text":"Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on the news. See our latest analysis for Align Technology. The upbeat reaction to the Philippines launch sits against a tougher backdrop, with a roughly 9% one month share price return, but a year to date share price return still down about 28%, and a one year total shareholder return of around minus 36%, suggesting momentum is only just starting to rebuild as investors reassess growth and competitive risks. If Align’s latest move has you thinking more broadly about healthcare opportunities, this could be a good moment to explore other healthcare stocks that are quietly reshaping patient care and investor expectations. With shares still well below their highs but trading on improving sentiment, the real debate now is whether Align’s recent weakness leaves the stock undervalued or if today’s price already bakes in a healthier growth trajectory. AdvertisementMost Popular Narrative Narrative: 16.4% Undervalued With Align Technology last closing at $150.93 versus a narrative fair value near $180.50, the current gap sets up a compelling valuation story driven by medium term earnings power.  The continued expansion of clinical indications for Invisalign (such as Invisalign First for teens/kids and palate expanders) and the increasing adoption by general practitioner dentists are broadening Align's addressable market, positioning the company for higher long term revenues and double digit earnings growth as these new segments mature.  Read the complete narrative. Curious how steady, not explosive, revenue growth could still justify a richer earnings multiple and rising margins over time, even as share count falls and cash flows are discounted at a measured rate? The most followed narrative stitches these moving parts together into one bold fair value target, but the exact growth runway, margin lift, and earnings bridge sit just out of sight. Want to see the full playbook behind that gap to intrinsic value and the assumptions it makes about Align’s next few years? Result: Fair Value of $180.50 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that upside case hinges on easing macro pressures and steadier orthodontic demand, both of which are vulnerable to weaker consumer confidence and shifting preferences back toward traditional braces. Find out about the key risks to this Align Technology narrative. Another Way to Look at Value While the narrative suggests Align is about 16% undervalued, its 28.6 times price to earnings ratio actually sits slightly above both peer and industry averages, 27.9 times and 28.4 times, yet below a fair ratio of 30.5 times. This hints at only modest upside and real re rating risk if growth disappoints. See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:ALGN PE Ratio as at Dec 2025 Build Your Own Align Technology Narrative If you see the story differently or want to stress test the assumptions with your own inputs, you can build a fresh narrative in minutes: Do it your way. A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Align Technology. Ready for your next investing move? Before the market’s next swing leaves you on the sidelines, put your strategy to work with focused screeners that surface ideas aligned with your goals.  Capture early stage momentum by scanning these 3576 penny stocks with strong financials that already show financial strength instead of chasing hype after prices have run. Position your portfolio at the forefront of intelligent automation with these 24 AI penny stocks that pair real business traction with AI powered growth potential. Identify value opportunities using these 927 undervalued stocks based on cash flows that trade below their cash flow based estimates before the broader market reacts.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588043140","isCrawlerRequest":true}